Takeda Pharmaceutical (TAK) Free Cash Flow (2018 - 2026)
Takeda Pharmaceutical's Free Cash Flow came in at $1.14 billion for the quarter ended Jun 30, 2026, down 37.5% from $1.82 billion a year earlier and down 31.8% from the prior quarter.
Powered by 
Analysis
Takeda Pharmaceutical (TAK) Free Cash Flow (2018 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Takeda Pharmaceutical reported Free Cash Flow of $12.34 billion, up 0.3% year-over-year; for the year ended Mar 31, 2026, it was $8.09 billion, down 2.1% from the prior year.
- Free Cash Flow carries a five-year compound annual growth rate of -5.2% (years ended Mar 2021 to Mar 2026).
- Going back by year, Free Cash Flow was $8.26 billion in the year ended Mar 31, 2025 (+33.6%), $6.18 billion in the year ended Mar 31, 2024 (-25.3%), $8.27 billion in the year ended Mar 31, 2023 (-25.5%) and $11.1 billion in the year ended Mar 31, 2022 (+4.9%).
- The figure for the quarter ended Jun 30, 2026 represents the lowest quarterly Free Cash Flow since the quarter ended Jun 30, 2023.
- Year-over-year, Free Cash Flow has declined for three consecutive quarters, with growth averaging 18.5% over the last eight quarters.
- The fastest year-over-year change in Free Cash Flow over five years came in the quarter ended Dec 31, 2024 (growth of 115.4%), and the weakest in the quarter ended Mar 31, 2022 (a decline of 65.2%).
- Business Quant data shows TAK's Free Cash Flow at $1.67 billion (quarter ended Mar 31, 2026), $2.7 billion (quarter ended Dec 31, 2025) and $6.83 billion (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 7.30 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.11 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 4.48 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 6.20 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 5.34 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 3.49 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.43 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 302.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.01 Bn |
| 10 | Takeda Pharmaceutical | 2.63 Bn | -23.88 Bn | 5.10 Bn | 1.14 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.14 Bn |
| Mar 31, 2026 | 1.67 Bn |
| Dec 31, 2025 | 2.70 Bn |
| Sep 30, 2025 | 6.83 Bn |
| Jun 30, 2025 | 1.82 Bn |
| Mar 31, 2025 | 1.73 Bn |
| Dec 31, 2024 | 2.82 Bn |
| Sep 30, 2024 | 5.93 Bn |
| Jun 30, 2024 | 1.46 Bn |
| Mar 31, 2024 | 1.45 Bn |
| Dec 31, 2023 | 1.31 Bn |
| Sep 30, 2023 | 4.99 Bn |
| Jun 30, 2023 | 1.01 Bn |
| Mar 31, 2023 | 968.95 Mn |
| Dec 31, 2022 | 2.91 Bn |
| Sep 30, 2022 | 5.62 Bn |
| Jun 30, 2022 | 977.11 Mn |
| Mar 31, 2022 | 1.44 Bn |
| Jun 30, 2021 | 1.80 Bn |
| Mar 31, 2021 | 4.13 Bn |
API Access
Takeda Pharmaceutical Free Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=free-cash-flow&ticker=TAK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "free-cash-flow", "ticker": "TAK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=free-cash-flow&ticker=TAK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();